MEDIPOST Co., Ltd. (KOSDAQ:078160)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,370
-790 (-4.60%)
Oct 30, 2025, 3:30 PM KST
-4.60%
Market Cap670.71B
Revenue (ttm)72.17B
Net Income (ttm)-99.09B
Shares Out39.09M
EPS (ttm)-2,906.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume159,516
Average Volume138,953
Open17,500
Previous Close17,160
Day's Range16,020 - 17,500
52-Week Range6,430 - 17,500
Beta0.66
RSI62.89
Earnings DateNov 13, 2025

About MEDIPOST

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 322
Stock Exchange KOSDAQ
Ticker Symbol 078160
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.